FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used in treatment of patients with generalised (disseminated) forms of renal cell carcinoma. Method is realised in the following way. Reaferon is introduced to patients intramuscularly, starting with 1 mln U, under control of body temperature dynamics and content of lymphocytes in leukocyte formula of blood. Reaferon dose is increased on 1 mln U with each next, in 1-2 days introduction, until body temperature rises to 37.5-38.0 degrees Celsius and will remain such during 2-3 hours after reaferon introduction, content of lymphocytes in leukocyte formula of blood a day after introduction being within 21-33%.
EFFECT: application of invention allows to reduce dimensions of metastases with monotherapy with reaferon due to adjustment of optimal reaferon dose depending on adaptive response of organism, reduce number of side effects and complications.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF IMMUNOTHERAPY OF RHENAL CELL CARCINOMA | 2010 |
|
RU2449770C2 |
METHOD OF TREATMENT OF DISSEMINATED RENAL CELL CANCER | 2017 |
|
RU2681300C1 |
METHOD OF TREATING PROSTATE CANCER | 2009 |
|
RU2420293C1 |
METHOD FOR PREVENTING METASTASES RECURRENCE IN URINARY PATH CANCER PATIENTS | 1996 |
|
RU2152811C1 |
METHOD FOR TREATING MALIGNANT NEOPLASM FORMATION IN KIDNEY AND URINARY BLADDER | 1992 |
|
RU2068709C1 |
METHOD FOR TREATING THE CASES OF RENAL CARCINOMA | 2001 |
|
RU2204331C2 |
METHOD OF TREATING SIGNET-RING CELL CARCINOMA OF STOMACH | 2009 |
|
RU2414890C1 |
METHOD OF CHEMOTHERAPY AT BLADDER CANCER | 2007 |
|
RU2352340C1 |
METHOD FOR TREATING CEREBRAL METASTASES OF GENERALIZED SKIN MELANOMA | 2005 |
|
RU2286146C1 |
LUNG CANCER THERAPY | 2009 |
|
RU2406452C1 |
Authors
Dates
2010-08-27—Published
2009-04-16—Filed